Journey Medical Corporation
DERM
$7.69
$0.283.78%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/2/2025
-
Tickeron - Stocks
12/2/2025
-
Tickeron - Stocks
11/29/2025
-
Tickeron - Stocks
11/28/2025
-
MarketBeat
11/26/2025
-
Tickeron - Stocks
11/25/2025
-
MarketBeat
11/22/2025
-
Tickeron - Stocks
11/21/2025
-
Tickeron - Stocks
11/20/2025
-
Tickeron - Stocks
11/20/2025
-
Tickeron - Stocks
11/19/2025
-
Insider Monkey
11/19/2025
-
Yahoo! Finance: News
11/19/2025
-
Tickeron - Stocks
11/18/2025
-
Tickeron - Stocks
11/18/2025
-
GuruFocus
11/17/2025
-
GuruFocus
11/17/2025
-
MarketBeat
11/15/2025
-
MarketBeat
11/15/2025
-
MarketBeat
11/15/2025
-
TipRanks Financial Blog
11/14/2025
-
ETF Channel
11/14/2025
-
Tickeron - Stocks
11/14/2025
-
Tickeron - Stocks
11/14/2025
-
Tickeron - Stocks
11/14/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
480 434 6670
Address
9237 East Via de Ventura Boulevard
Scottsdale, AZ 85258
Scottsdale, AZ 85258
Country
Year Founded
Business Description
Sector
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed...
more